 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Foundations of Proto-Oncogenes and Cancer Signaling

Course Orientation: Oncogenes and RTK Signaling

Normal Cellular Growth Control

Proto-Oncogenes, Oncogenes, and Tumor Suppressor Genes

Receptor Tyrosine Kinases as Signal Initiators

Structure and Function of Receptor Tyrosine Kinases

RTK Activation and Signal Relay

Examples of Cancer-Relevant RTK Alterations

Mechanisms of Proto-Oncogene Activation

Activating Mutations

Gene Amplification and Oncogene Overexpression

Chromosomal Translocations and Fusion Oncogenes

Comparing Oncogene Activation Mechanisms

The RAS-RAF-MEK-ERK Signaling Cascade

RAS Activation Downstream of RTKs

RAF, MEK, and ERK Signal Transmission

Oncogenic Disruption of the MAPK Pathway

The PI3K-AKT-mTOR Signaling Cascade

PI3K Activation and Membrane Signaling

AKT and mTOR in Cell Survival and Growth

Oncogenic Alterations in the PI3K-AKT-mTOR Pathway

Pathway Integration and Clinical Relevance

Shared RTK Outputs and Pathway Cross-Talk

From Molecular Alteration to Targeted Therapy

Course Synthesis: Interpreting an Oncogenic Signaling Scenario

Quiz

Which event most directly initiates signaling by a typical receptor tyrosine kinase after growth-factor binding?

Which proto-oncogene activation mechanism increases the number of copies of a gene, often leading to overexpression of its protein product?

What is the principal molecular effect of an activating RAS mutation?

Place the core MAPK pathway components in the correct order downstream of activated RAS.

Which statement best summarizes the role of the PI3K-AKT-mTOR pathway in cancer cells?

Survey and Feedback

Course Feedback Survey: How effectively did this course support your understanding of oncogenes and RTK signaling?

Welcome to "Oncogene Activation and Receptor Tyrosine Kinase Signaling Pathways," a comprehensive online course designed to unravel the complex molecular mechanisms driving cancer development. In this course, you will explore the critical transition from normal cellular growth control to the persistent, unregulated signaling that characterizes malignancy.

Welcome to "Oncogene Activation and Receptor Tyrosine Kinase Signaling Pathways," a comprehensive online course designed to unravel the complex molecular mechanisms driving cancer development. In this course, you will explore the critical transition from normal cellular growth control to the persistent, unregulated signaling that characterizes malignancy. We begin by establishing a strong foundation in proto-oncogenes, oncogenes, and tumor suppressor genes, highlighting how normal cellular regulation can be hijacked by genetic alterations.

You will dive deep into Receptor Tyrosine Kinases (RTKs) as primary signal initiators, examining their structure, activation, and the specific alterations—such as EGFR mutations and HER2 amplifications—that make them potent drivers of cancer. The curriculum meticulously breaks down the mechanisms of proto-oncogene activation, including activating mutations, gene amplifications, and chromosomal translocations.

Furthermore, the course provides an in-depth analysis of two major intracellular signaling cascades: the RAS-RAF-MEK-ERK (MAPK) pathway and the PI3K-AKT-mTOR pathway. You will learn how these pathways regulate cell proliferation, survival, and metabolism, and how their oncogenic disruption leads to tumor growth. Finally, we bridge molecular biology with clinical application by exploring pathway cross-talk and the principles of targeted therapies, empowering you to understand how molecular testing informs modern oncology treatments. Join us to master the signaling pathways at the heart of cancer biology and targeted therapeutics.

Oncogene Activation and Receptor Tyrosine Kinase Signaling Pathways

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The study of cellular growth and regulation is fundamental to understanding cancer biology. This course provides a comprehensive examination of oncogene activation and receptor tyrosine kinase (RTK) signaling pathways. It begins by establishing the foundational principles of normal cellular growth control and the critical distinctions between proto-oncogenes, oncogenes, and tumor suppressor genes. By exploring the structure and function of RTKs, learners will understand how these membrane-bound receptors act as primary signal initiators in response to extracellular growth factors. The curriculum details the precise mechanisms through which proto-oncogenes are abnormally activated—specifically through activating mutations, gene amplification, and chromosomal translocations—transforming normal physiological processes into persistently activated, cancer-driving signaling networks.</p>

<p>Building upon these foundational mechanisms, the course systematically dissects two major intracellular signaling cascades: the RAS-RAF-MEK-ERK pathway and the PI3K-AKT-mTOR pathway. Detailed modules sequence the transmission of signals from activated RTKs through these cascades, highlighting their respective roles in cellular proliferation, survival, and metabolism. Furthermore, the curriculum addresses the complex integration and cross-talk between these pathways, illustrating how oncogenic disruptions can lead to therapeutic resistance and tumor progression. Ultimately, this comprehensive analysis culminates in the clinical relevance of these molecular alterations, demonstrating how identifying specific genomic events informs the development and application of targeted therapeutic strategies in modern oncology.</p>
        </div>
    </div>
</div>
